Villagers who use Storth’s community shop and post office have helped charity Rosemere Cancer Foundation to receive a £500 community award.
The award is a share of profits from the village owned and run business, which uses its profit margins to support a number of local good causes. Rosemere’s award is its fourth consecutive award, taking the total donation it has received from the co-operative to £3,000 since 2016.
Storth Community Co-operative member Lesley Drummond, who is also a member of Rosemere Cancer Foundation’s Dallam Group of supporters, said: “A number of local people have been in treatment for cancer and have become aware of the foundation and its work so the award is our community’s way of saying thank you.”
Accepting the award on behalf of Rosemere Cancer Foundation was its South Cumbria and North Lancashire fundraising co-ordinator Julie Hesmondhalgh, who said: “We are extremely grateful for this donation and the support of the local community.
“We have brought a number of projects to fruition to benefit local cancer patients this year among them funding a major new bowel cancer trial, supplying a portable ultrasound machine to speed up head and neck cancer diagnosis and ensuring cancer patients throughout the area have free access to complementary therapies. Our pledge is to continue and grow our workload into the future.”
Rosemere Cancer Foundation was nominated for the award by villager and volunteer shop assistant Alison Charlesworth, former headmistress of Storth CE Primary School, who is also a member of the charity’s Dallam Group.
Rosemere Cancer Foundation works to bring world class cancer treatments and services to cancer patients from throughout South Cumbria and Lancashire being treated at Rosemere Cancer Centre, the region’s specialist cancer treatment centre at the Royal Preston Hospital, and at another eight local hospital cancer units across the two counties, including those at Westmorland and Furness General Hospitals and the Royal Lancaster Infirmary.
The charity funds cutting edge equipment, research, training and other cancer services and therapies that the NHS is unable to afford.